Life sciences company Avacta has appointed Tony Gardiner as group chief financial officer, it has been announced.
Mr Gardiner will take up his position on January 4, 2016.
The current incumbent, Tim Sykes, leaves the company today (December 10) to pursue other business interests. Chief operating officer, Craig Slater, will serve as interim chief financial officer in the meantime.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze